Phase 1 Randomized Trial of the Vaginal Safety and Acceptability of SPL7013 Gel (VivaGel) in Sexually Active Young Women (MTN-004)

AIDS - United States
doi 10.1097/qad.0b013e328346bd3e
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

A Phase 1 Randomized, Double Blind, Placebo Controlled Rectal Safety and Acceptability Study of Tenofovir 1% Gel (MTN-007)

PLoS ONE
Multidisciplinary
2013English

A Phase 1 Trial to Assess the Safety, Acceptability, Pharmacokinetics, and Pharmacodynamics of a Novel Dapivirine Vaginal Film

Journal of Acquired Immune Deficiency Syndromes
Infectious DiseasesPharmacology
2016English

Acceptability of Tenofovir Gel as a Vaginal Microbicide Among Women in a Phase I Trial: A Mixed-Methods Study

Journal of Women's Health
Medicine
2008English

Safety and Acceptability of Clozapine and Risperidone in Progressive Multiple Sclerosis: A Phase 1, Randomized, Blinded, Placebo-Controlled Trial

2020English

A Phase 1 Randomized Placebo-Controlled Safety and Pharmacokinetic Trial of a Tenofovir Disoproxil Fumarate Vaginal Ring

AIDS
Infectious DiseasesAllergyImmunology
2016English

Investigation of Vaginal Microbiota in Sexually Active Women Using Hormonal Contraceptives in Pakistan

BMC Urology
MedicineReproductive MedicineUrology
2012English

Confusion Regarding Cervical Cancer Screening and Chlamydia Screening Among Sexually Active Young Women: Table 1

Sexually Transmitted Infections
DermatologyInfectious Diseases
2011English

Safety and Immunogenicity of the Recombinant BCG Vaccine AERAS-422 in Healthy BCG-naïve Adults: A Randomized, Active-Controlled, First-In-Human Phase 1 Trial

EBioMedicine
BiochemistryMedicineGeneticsMolecular Biology
2016English

SAVVY Vaginal Gel (C31G) for Prevention of HIV Infection: A Randomized Controlled Trial in Nigeria

PLoS ONE
Multidisciplinary
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy